Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-24 Sale | 2019-09-26 4:16 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 16,700 | $1.19 | $19,873 | 616,389 (Indirect) | View |
| 2019-09-20 Sale | 2019-09-24 4:08 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 112,361 | $1.4898 | $167,398 | 633,089 (Indirect) | View |
| 2019-09-18 Sale | 2019-09-20 4:05 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 49,995 | $2.1005 | $105,014 | 745,450 (Indirect) | View |
| 2019-09-11 Sale | 2019-09-13 4:24 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 1,247 | $2.7526 | $3,432 | 795,445 (Indirect) | View |
| 2019-09-09 Sale | 2019-09-11 4:16 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 400 | $2.765 | $1,106 | 796,692 (Indirect) | View |
| 2019-09-05 Sale | 2019-09-09 4:10 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 5,415 | $2.7801 | $15,054 | 797,092 (Indirect) | View |
| 2019-07-09 Sale | 2019-07-11 4:43 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 10,927 | $2.828 | $30,901 | 802,507 (Indirect) | View |
| 2019-06-27 Sale | 2019-07-01 4:35 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 1,458 | $3.4465 | $5,025 | 813,434 (Indirect) | View |
| 2019-06-25 Sale | 2019-06-27 4:21 pm | Onconova Therapeutics Inc. | ONTX | TYNDALL CAPITAL PARTNERS L P 10% Owner | 1,380 | $3.3976 | $4,689 | 814,892 (Indirect) | View |